NBCF welcomes BONDS’ commitment to fund breast cancer research

October 31st, 2013

NBCF has been in discussion with Bonds for some time over the campaign to launch Bonds’ new bra range.

NBCF and Bonds have partnered before to raise funds for research, and both wanted to do so again. In our discussions with Bonds, NBCF was very careful to emphasize that breast cancer must be seen in the context of the whole woman. That is why we have a commitment to fund research right across the full spectrum of the breast cancer experience.

Bonds has used the word ‘BOOBS’ in their campaign, as it reflects the brand’s personality and the general Australian vernacular.

NBCF worked with Bonds to ensure that respect and care for the whole woman and her health was woven through elements of the campaign, other than the title.

The partnership between Bonds and NBCF goes back to 2007 with the company raising more than $500,000 for breast cancer research through the sale of Pink Ribbon products.

NBCF CEO, Carole Renouf, states: “As the Foundation receives no government funding, we can only achieve our goal of zero deaths from breast cancer by 2030 through corporate and community support for research”.

‘When NBCF was established in 1994, 30% of women diagnosed with breast cancer lost their lives. Today that percentage has halved through advances in research and early detection in which Australia’s excellent free government breast screening program has played a large part,” she said.

“At NBCF, we believe the health of the whole woman is important so we fund research across the spectrum of breast cancer – from understanding the fundamental basis of the disease to psychosocial research aimed at improving quality of life for those people living with a breast cancer diagnosis and their families.”

In keeping with the direction of the new BONDS campaign, Ms Renouf said NBCF was currently funding important research aimed at improving early detection of breast cancer. This includes a team from the University of Queensland who are using nanotechnology to develop a blood test for this purpose.